Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-19T02:50:49.848Z Has data issue: false hasContentIssue false
  • English
  • Français

Legionella pneumonia with acute respiratory distress syndrome, myocarditis and septic shock successfully treated with Drotrecogin Alpha (activated)

Published online by Cambridge University Press:  03 August 2006

H. Bodur ,
Y. Savran ,
U. Koca ,
O. Kilinç ,
S. Albayrak ,
O. Itil  and
S. Akoğlu
H. Bodur
Affiliation:
Department of Internal Medicine, Dokuz Eylül University, School of Medicine, İzmir, Turkey
Y. Savran
Affiliation:
Department of Internal Medicine, Dokuz Eylül University, School of Medicine, İzmir, Turkey
U. Koca
Affiliation:
Department of Anesthesiology and Reanimation, Dokuz Eylül University, School of Medicine, İzmir, Turkey
O. Kilinç
Affiliation:
Department of Chest Diseases, Dokuz Eylül University, School of Medicine, İzmir, Turkey
S. Albayrak
Affiliation:
Department of Chest Diseases, Dokuz Eylül University, School of Medicine, İzmir, Turkey
O. Itil
Affiliation:
Department of Chest Diseases, Dokuz Eylül University, School of Medicine, İzmir, Turkey
S. Akoğlu
Affiliation:
Department of Chest Diseases, Mustafa Kemal University, School of Medicine, Hatay, Turkey
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
European Journal of Anaesthesiology , Volume 23 , Issue 9 , September 2006 , pp. 808 - 810
Copyright
2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ely EW, Laterre PF, Angus DCet al. PROWESS Investigators. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003; 31 (1): 12–19.Google Scholar
van Riemsdijk-van Overbeeke IC, van den Berg. Severe Legionnaire's disease requiring intensive care treatment. Neth J Med 1996; 49 (5): 196–201.Google Scholar
Gacouin A, Le Tulzo Y, Lavoue Set al. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med 2002; 28 (6): 686–691.Google Scholar
el-Ebiary M, Sarmiento X, Torres Aet al. Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am J Respir Crit Care Med 1997; 156 (5): 1467–1472.Google Scholar
Karim A, Ahmed S, Rossoff LJ. Legionnaire's disease associated with acute encephalitis and arrhythmia. Crit Care Med 2002; 30 (5): 1028–1029.Google Scholar
Grangeon V, Vincent L, Pacheco Y. Digestive disorders and Legionnaires' lung disease. Accompanying signs or visceral location? Rev Mal Resp 2000; 17 (2): 489–492.Google Scholar
Hirani NA, Macfarlane JT. Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax 1997; 52 (1): 17–21.Google Scholar
Rello J, Quintana E, Ausina V, Net A, Prats G. A three year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993; 103 (1): 232–235.Google Scholar
Laterre PF, Garber G, Levy Het al. For the PROWESS Clinical Evaluation Committee. Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study. Crit Care Med 2003; 33 (5): 952–961.Google Scholar